Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Clinical Lab Management › With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

With Sputum Test for SARS-CoV-2, MicroGen Dx Aims to Challenge Quest, LabCorp

Apr 03, 2020
|
Kelsy Ketchum

The story has been updated to clarify that Quest and LabCorp's tests for the coronavirus were cleared for use with sputum samples. 

NEW YORK – Although hundreds of labs across the US have been providing testing for SARS-CoV-2, Quest Diagnostics and Laboratory Corporation of America are the industry's leaders and have provided hundreds of thousands of tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In PCR

  1. Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

  2. FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

  3. Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

  4. LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test

  5. FDA Relaxes Rules for Flu, RSV Molecular Tests During Coronavirus Health Emergency

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.